Mucormycosis, The Black Fungus alarming Coinfections in Covid-19 Patients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic causing disease 2019 (COVID-19). It was firstly reported in Hubei province the People’s Republic of China and spread worldwide quickly. COVID-19 affects every person differently, from mild to life-threatening symptoms (Nawaz, 2020), along with other bacterial or fungal co-infections (CDC., 2021). affected patients are prone develop opportunistic infections (Salehi et al., 2020). immune system SARS-COV-2 infected becomes vulnerable these if some comorbidities (diabetes, pulmonary disease) immunocompromised conditions (steroid therapy, hospital stay, ventilation) present. development such Pneumocystis jiroveci pneumonia, bloodstream candida, aspergillosis, oropharyngeal candidiasis have been SARS-CoV-2 (Moorthy A few case reports rhino-orbital mucormycosis (Mehta One study by (Sen 2021), which they presented series six cases mucormycosis. Only one patient this had concurrent at admission, while five developed during treatment for COVID-19. Recent studies Pakistan an increased number mucormycosis, also known “black fungus” (The News.,